HomeProductsBioactive CompoundsApoptosisMDM2Ro-5045337
Chemical structure of CAS 939981-39-2

Ro-5045337

CAS No.939981-39-2
MDL No.MFCD18206914
MFC38H48Cl2N4O4S
MW727.80
InChI KeyQBGKPEROWUKSBK-QPPIDDCLSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.939981-39-2
Product NameRo-5045337

Associated Conditions

sarcoma·neoplasm·hematopoietic and lymphoid cell neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells.

Cell death & disease • Vol. 9, Issue 8 • 2018
PMID: 30022047PMC: PMC6052082DOI: 10.1038/s41419-018-0825-1

p53 and NF-κB coregulate proinflammatory gene responses in human macrophages.

Cancer research • Vol. 74, Issue 8 • 2014
PMID: 24737129PMC: PMC3994464DOI: 10.1158/0008-5472.CAN-13-1070

Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development.

ACS medicinal chemistry letters • Vol. 4, Issue 5 • 2013
PMID: 24900694PMC: PMC4027145DOI: 10.1021/ml4000657

Documentation

Similar Products